193 related articles for article (PubMed ID: 16195592)
1. Synthesis and activity of tyropeptin A derivatives as potent and selective inhibitors of mammalian 20S proteasome.
Momose I; Umezawa Y; Hirosawa S; Iijima M; Iinuma H; Ikeda D
Biosci Biotechnol Biochem; 2005 Sep; 69(9):1733-42. PubMed ID: 16195592
[TBL] [Abstract][Full Text] [Related]
2. Structure-based design of derivatives of tyropeptin A as the potent and selective inhibitors of mammalian 20S proteasome.
Momose I; Umezawa Y; Hirosawa S; Iinuma H; Ikeda D
Bioorg Med Chem Lett; 2005 Apr; 15(7):1867-71. PubMed ID: 15780623
[TBL] [Abstract][Full Text] [Related]
3. Tyropeptins, proteasome inhibitors produced by Kitasatospora sp. MK993-dF2.
Momose I; Watanabe T
J Antibiot (Tokyo); 2017 May; 70(5):542-550. PubMed ID: 28196975
[TBL] [Abstract][Full Text] [Related]
4. Tyropeptins A and B, new proteasome inhibitors produced by Kitasatospora sp. MK993-dF2. I. Taxonomy, isolation, physico-chemical properties and biological activities.
Momose I; Sekizawa R; Hashizume H; Kinoshita N; Homma Y; Hamada M; Iinuma H; Takeuchi T
J Antibiot (Tokyo); 2001 Dec; 54(12):997-1003. PubMed ID: 11858671
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of boronic acid derivatives of tyropeptin: proteasome inhibitors.
Watanabe T; Momose I; Abe M; Abe H; Sawa R; Umezawa Y; Ikeda D; Takahashi Y; Akamatsu Y
Bioorg Med Chem Lett; 2009 Apr; 19(8):2343-5. PubMed ID: 19307118
[TBL] [Abstract][Full Text] [Related]
6. Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors.
Scotti A; Trapella C; Ferretti V; Gallerani E; Gavioli R; Marastoni M
J Enzyme Inhib Med Chem; 2016; 31(3):456-63. PubMed ID: 25942361
[TBL] [Abstract][Full Text] [Related]
7. Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and cellular properties of potent, selective proteasome inhibitors.
Rydzewski RM; Burrill L; Mendonca R; Palmer JT; Rice M; Tahilramani R; Bass KE; Leung L; Gjerstad E; Janc JW; Pan L
J Med Chem; 2006 May; 49(10):2953-68. PubMed ID: 16686537
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship of boronic acid derivatives of tyropeptin: proteasome inhibitors.
Watanabe T; Abe H; Momose I; Takahashi Y; Ikeda D; Akamatsu Y
Bioorg Med Chem Lett; 2010 Oct; 20(19):5839-42. PubMed ID: 20727746
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of proteasome activity by tyropeptin A in PC12 cells.
Momose I; Sekizawa R; Iinuma H; Takeuchi T
Biosci Biotechnol Biochem; 2002 Oct; 66(10):2256-8. PubMed ID: 12450145
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of naphthoquinone derivatives as antiproliferative agents and 20S proteasome inhibitors.
Xu K; Xiao Z; Tang YB; Huang L; Chen CH; Ohkoshi E; Lee KH
Bioorg Med Chem Lett; 2012 Apr; 22(8):2772-4. PubMed ID: 22437113
[TBL] [Abstract][Full Text] [Related]
11. Development of novel selective peptidomimetics containing a boronic acid moiety, targeting the 20S proteasome as anticancer agents.
Scarbaci K; Troiano V; Ettari R; Pinto A; Micale N; Di Giovanni C; Cerchia C; Schirmeister T; Novellino E; Lavecchia A; Zappalà M; Grasso S
ChemMedChem; 2014 Aug; 9(8):1801-16. PubMed ID: 24891205
[TBL] [Abstract][Full Text] [Related]
12. Activity enhancement of the synthetic syrbactin proteasome inhibitor hybrid and biological evaluation in tumor cells.
Archer CR; Groll M; Stein ML; Schellenberg B; Clerc J; Kaiser M; Kondratyuk TP; Pezzuto JM; Dudler R; Bachmann AS
Biochemistry; 2012 Aug; 51(34):6880-8. PubMed ID: 22870914
[TBL] [Abstract][Full Text] [Related]
13. Novel beta-lactam derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome.
Imbach P; Lang M; García-Echeverría C; Guagnano V; Noorani M; Roesel J; Bitsch F; Rihs G; Furet P
Bioorg Med Chem Lett; 2007 Jan; 17(2):358-62. PubMed ID: 17095212
[TBL] [Abstract][Full Text] [Related]
14. Alpha,beta-unsaturated N-acylpyrrole peptidyl derivatives: new proteasome inhibitors.
Baldisserotto A; Ferretti V; Destro F; Franceschini C; Marastoni M; Gavioli R; Tomatis R
J Med Chem; 2010 Sep; 53(17):6511-5. PubMed ID: 20687609
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of novel spin labeled 18β-glycyrrhetinic acid derivatives.
Liu Y; Qian K; Wang CY; Chen CH; Yang X; Lee KH
Bioorg Med Chem Lett; 2012 Dec; 22(24):7530-3. PubMed ID: 23122524
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel non-peptide boronic acid derivatives as proteasome inhibitors.
Ge Y; Li A; Wu J; Feng H; Wang L; Liu H; Xu Y; Xu Q; Zhao L; Li Y
Eur J Med Chem; 2017 Mar; 128():180-191. PubMed ID: 28182990
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of a novel class of furan-based molecules as potential 20S proteasome inhibitors.
Fu Y; Xu B; Zou X; Ma C; Yang X; Mou K; Fu G; Lü Y; Xu P
Bioorg Med Chem Lett; 2007 Feb; 17(4):1102-6. PubMed ID: 17134894
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of tyropeptin-boronic acid derivatives: New proteasome inhibitors.
Momose I; Abe H; Watanabe T; Ohba S; Yamazaki K; Dan S; Yamori T; Masuda T; Nomoto A
Cancer Sci; 2014 Dec; 105(12):1609-15. PubMed ID: 25251038
[TBL] [Abstract][Full Text] [Related]
19. Terminal functionalized thiourea-containing dipeptides as multidrug-resistance reversers that target 20S proteasome and cell proliferation.
Qin JM; Huang RZ; Yao GY; Liao ZX; Pan YM; Wang HS
Eur J Med Chem; 2017 Jan; 126():259-269. PubMed ID: 27889629
[TBL] [Abstract][Full Text] [Related]
20. A new structural class of selective and non-covalent inhibitors of the chymotrypsin-like activity of the 20S proteasome.
García-Echeverría C; Imbach P; France D; Fürst P; Lang M; Noorani AM; Scholz D; Zimmermann J; Furet P
Bioorg Med Chem Lett; 2001 May; 11(10):1317-9. PubMed ID: 11392545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]